Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trialArlene O. Siefker‐Radtke, Wei Xue, Nobuaki Matsubara et al.|Annals of Oncology|2023Cited by 82
“Burnout in Medical Oncology Fellows: a Prospective Multicenter Cohort Study in Brazilian Institutions”Daniel de Iracema Gomes Cubero, Auro del Giglio, Felipe Osório Costa et al.|Journal of Cancer Education|2015Cited by 47